{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:06:50Z","timestamp":1794917210520,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cost Eff Resour Alloc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Congenital cytomegalovirus (cCMV) infection can cause severe neurological damage, growth retardation, hearing loss, and microcephaly in infants. We aimed at assessing healthcare costs of infants with recorded cCMV diagnosis in an administrative claims database in the first 2\u00a0years of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective, controlled cohort study using German claims data from the Institute for Applied Health Research Berlin (InGef) database. Incremental healthcare costs during the first and second year of life were assessed by matching (1:60) infants with cCMV diagnoses\u2009\u2264\u200990\u00a0days after birth (cCMV<jats:sub>90<\/jats:sub> cohort) to infants without cCMV diagnosis (\u201crepresentative\u201d controls) and infants with cCMV diagnoses\u2009\u2264\u200921\u00a0days after birth plus specific symptoms (cCMV<jats:sub>21-S<\/jats:sub>) to infants without cCMV and any ICD-10-GM records (besides Z00-Z99) until 4<jats:sup>th<\/jats:sup> preventive health check-up (\u201chealthy\u201d controls). Due to missing data, mean imputation was applied for aids and remedies costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 54 and 24 infants born 2014\u20132018 for the cCMV<jats:sub>90<\/jats:sub> and cCMV<jats:sub>21-S<\/jats:sub> cohorts, respectively. During the first year, mean (median) healthcare costs were significantly higher in cCMV<jats:sub>90<\/jats:sub> cases vs. \u201crepresentative\u201d controls (\u20ac22,737 (\u20ac9759) vs. \u20ac3091 (\u20ac863), p\u2009&lt;\u20090.001), with 87.2% inpatient costs. Healthcare costs for cCMV<jats:sub>21-S<\/jats:sub> cases compared to \u201chealthy\u201d controls were \u20ac34,498 (\u20ac20,924) vs. \u20ac680 (\u20ac569), p\u2009&lt;\u20090.001. Differences decreased for both comparisons in the second year but remained statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>cCMV comprises a considerable economic burden for the German healthcare system (\u20ac19,646 to \u20ac33,818 higher mean costs for infants with recorded cCMV diagnosis in the first year of life). Attempts should be made to reduce this burden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12962-022-00411-x","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:02:59Z","timestamp":1674482579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Anna-Janina","family":"Stephan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"de Lepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"W\u00f6lle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Luzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Maren","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Buxmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangmar","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Hamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Modrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Reuschenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"4","key":"411_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202\u201313.","journal-title":"Rev Med Virol"},{"issue":"4","key":"411_CR2","first-page":"45","volume":"114","author":"H Buxmann","year":"2017","unstructured":"Buxmann H, Hamprecht K, Meyer-Wittkopf M, Friese K. Primary human cytomegalovirus (HCMV) infection in pregnancy. Deutsches Arzteblatt Int. 2017;114(4):45\u201352.","journal-title":"Deutsches Arzteblatt Int"},{"key":"411_CR3","first-page":"107","volume":"49","author":"S Modrow","year":"2018","unstructured":"Modrow S, Buxmann H, Enders M, Gembruch U, Goelz R, Hamprecht K, et al. Management der kongenitalen Zytomegalievirus-Infektion bei Neugeborenen. Kinder Jugendarzt. 2018;49:107\u201317.","journal-title":"Kinder Jugendarzt"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2458-5-70","volume":"5","author":"MJ Cannon","year":"2005","unstructured":"Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health. 2005;5:70.","journal-title":"BMC Public Health"},{"issue":"9","key":"411_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2807\/ese.14.09.19140-en","volume":"14","author":"A Ludwig","year":"2009","unstructured":"Ludwig A, Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. EuroSurveillance. 2009;14(9):26\u201332.","journal-title":"EuroSurveillance."},{"issue":"2","key":"411_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00404-017-4435-4","volume":"296","author":"H R\u00fctten","year":"2017","unstructured":"R\u00fctten H, Rissmann A, Brett B, Costa S-D, Do\u00dfow B, F\u00e4rber J, et al. Congenital cytomegalovirus infection in Central Germany: an underestimated risk. Arch Gynecol Obstet. 2017;296(2):231\u201340.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"411_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355\u201363.","journal-title":"Rev Med Virol"},{"issue":"5","key":"411_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/archdischild-2017-312805","volume":"103","author":"MJ Korndewal","year":"2018","unstructured":"Korndewal MJ, Weltevrede M, van den Akker-van Marle ME, Oudesluys-Murphy AM, de Melker HE, Vossen A. Healthcare costs attributable to congenital cytomegalovirus infection. Arch Dis Child. 2018;103(5):452\u20137.","journal-title":"Arch Dis Child"},{"key":"411_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-319-98770-5_7","volume-title":"Congenital cytomegalovirus infection: epidemiology, diagnosis, therapy","author":"E Walter","year":"2018","unstructured":"Walter E, Brennig C, Sch\u00f6llbauer V, Halwachs-Baumann G. How to save money: congenital CMV infection and the economy. In: Halwachs-Baumann G, editor. Congenital cytomegalovirus infection: epidemiology, diagnosis, therapy. Cham: Springer International Publishing; 2018. p. 121\u201344."},{"key":"411_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/apa.15305","volume":"110","author":"N L\u00fcsebrink","year":"2021","unstructured":"L\u00fcsebrink N, Kieslich M, Rabenau HF, Schl\u00f6\u00dfer RL, Buxmann H. Retrospectively diagnosing congenital cytomegalovirus infections in symptomatic infants is challenging. Acta Paediatr. 2021;110:197\u2013202.","journal-title":"Acta Paediatr"},{"issue":"2","key":"411_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/03007995.2021.2006536","volume":"38","author":"A Campione","year":"2022","unstructured":"Campione A, Lanzieri TM, Ricotta E, Grosse SD, Kadri SS, Nussenblatt V, et al. Missing diagnoses of congenital cytomegalovirus infection in electronic health records for infants with laboratory-confirmed infection. Curr Med Res Opin. 2022;38(2):273\u20135.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"411_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/03007995.2021.1890556","volume":"37","author":"SD Grosse","year":"2021","unstructured":"Grosse SD, Leung J, Lanzieri TM. Identification of congenital CMV cases in administrative databases and implications for monitoring prevalence, healthcare utilization, and costs. Curr Med Res Opin. 2021;37(5):769\u201379.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"411_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/ijns8040060","volume":"8","author":"KL Wilson","year":"2022","unstructured":"Wilson KL, Shah K, Pesch MH. Inconsistent provider testing practices for congenital cytomegalovirus: missed diagnoses and missed opportunities. Int J Neonatal Screen. 2022;8(4):60.","journal-title":"Int J Neonatal Screen."},{"issue":"1","key":"411_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/pds.3895","volume":"25","author":"F Andersohn","year":"2016","unstructured":"Andersohn F, Walker J. Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf. 2016;25(1):106\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"411_CR15","unstructured":"Gesellschaft f\u00fcr Virologie e.V. (GfV). S2k-Leitlinie\u2014Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Berlin: Springer; 2014."},{"issue":"6","key":"411_CR16","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","volume":"17","author":"WD Rawlinson","year":"2017","unstructured":"Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"411_CR17","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/INF.0000000000001763","volume":"36","author":"SE Luck","year":"2017","unstructured":"Luck SE, Wieringa JW, Bl\u00e1zquez-Gamero D, Henneke P, Schuster K, Butler K, et al. Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017;36(12):1205\u201313.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"411_CR18","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.clinthera.2019.04.022","volume":"41","author":"J Meyers","year":"2019","unstructured":"Meyers J, Sinha A, Samant S, Candrilli S. The economic burden of congenital cytomegalovirus disease in the first year of life: a retrospective analysis of health insurance claims data in the United States. Clin Ther. 2019;41(6):1040-56.e3.","journal-title":"Clin Ther"},{"key":"411_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12962-019-0189-0","volume":"17","author":"A Lucas","year":"2019","unstructured":"Lucas A, Sinha A, Fowler KB, Mladsi D, Barnett C, Samant S, et al. A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States. Cost Eff Resour Alloc. 2019;17:21.","journal-title":"Cost Eff Resour Alloc."},{"issue":"11","key":"411_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/INF.0000000000000421","volume":"33","author":"AS Lopez","year":"2014","unstructured":"Lopez AS, Ortega-Sanchez IR, Bialek SR. Congenital cytomegalovirus-related hospitalizations in infants <\u00a01 year of age, United States, 1997\u20132009. Pediatr Infect Dis J. 2014;33(11):1119\u201323.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"411_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/archdischild-2018-316010","volume":"104","author":"J Retzler","year":"2019","unstructured":"Retzler J, Hex N, Bartlett C, Webb A, Wood S, Star C, et al. Economic cost of congenital CMV in the UK. Arch Dis Child. 2019;104(6):559\u201363.","journal-title":"Arch Dis Child"},{"issue":"2","key":"411_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.clinthera.2021.12.007","volume":"44","author":"C Weil","year":"2022","unstructured":"Weil C, Wang WV, Marks MA, Bilavsky E, Sinha A, Chodick G, et al. Health care resource utilization and economic burden associated with congenital cytomegalovirus infection: a longitudinal analysis of data from clinical practice at a large health care provider in Israel. Clin Ther. 2022;44(2):282\u201394.","journal-title":"Clin Ther"},{"issue":"1","key":"411_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12879-020-4941-z","volume":"20","author":"L Pellegrinelli","year":"2020","unstructured":"Pellegrinelli L, Alberti L, Pariani E, Barbi M, Binda S. Diagnosing congenital Cytomegalovirus infection: don\u2019t get rid of dried blood spots. BMC Infect Dis. 2020;20(1):217.","journal-title":"BMC Infect Dis"},{"key":"411_CR24","doi-asserted-by":"publisher","first-page":"151393","DOI":"10.1016\/j.semperi.2021.151393","volume":"45","author":"SD Grosse","year":"2021","unstructured":"Grosse SD, Dollard SC, Ortega-Sanchez IR. Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies. Semin Perinatol. 2021;45:151393.","journal-title":"Semin Perinatol."}],"container-title":["Cost Effectiveness and Resource Allocation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-022-00411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12962-022-00411-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12962-022-00411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T14:04:17Z","timestamp":1674482657000},"score":1,"resource":{"primary":{"URL":"https:\/\/resource-allocation.biomedcentral.com\/articles\/10.1186\/s12962-022-00411-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/s12962-022-00411-x","relation":{},"ISSN":["1478-7547"],"issn-type":[{"value":"1478-7547","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Anonymized SHI data were used for this study. The use of such data is not subject to ethics committee approval in Germany (Good Practice of Secondary Data Analysis (GPS)). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ML, RW, AL, and MR are full-time employees of MSD Sharp & Dohme GmbH. AJS was a full-time employee of MSD Sharp & Dohme GmbH at the time the study was performed. WW is a full-time employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. KMS and CJ are full-time employees of Xcenda GmbH, acting as contractors of MSD Sharp & Dohme GmbH for the execution of this study. WG received personal fees from Xcenda GmbH during the conduct of the study. RG, KH, PK, and SM received honoraria as scientific advisor from MSD Sharp & Dohme GmbH. HB received research grants (third-party funding), reimbursement of travel expenses, consulting fees or reimbursement of conference fees from the following companies related to the topic of 'cytomegalovirus infections': Biotest AG, MSD Sharp & Dohme GmbH, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and Hoffmann-La Roche Ltd. All authors have provided the ICMJE Form for Disclosure of Potential Conflicts of Interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}